Correction: Comparing the Efficacy, Safety, and Superiority of Calcitonin Gene-Related Peptide Monoclonal Antibodies and Botox in Preventing and Treating Migraines.


Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
12 Feb 2021
Historique:
entrez: 1 3 2021
pubmed: 2 3 2021
medline: 2 3 2021
Statut: epublish

Résumé

[This corrects the article DOI: 10.7759/cureus.13002.].

Identifiants

pubmed: 33643745
doi: 10.7759/cureus.c41
pmc: PMC7885304
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

c41

Commentaires et corrections

Type : ErratumFor

Informations de copyright

Copyright © 2021, Siddiqui et al.

Déclaration de conflit d'intérêts

No competing interests declared.

Auteurs

Mariah Siddiqui (M)

Neurology, St. George's University, True Blue, GRD.
Neurology, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Parth V Shah (PV)

Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Prachi Balani (P)

Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Angel R Lopez (AR)

Psychiatry, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Chelsea Mae N Nobleza (CMN)

Neurology, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Safeera Khan (S)

Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Classifications MeSH